Express Scripts Holding (NASDAQ:ESRX) – Research analysts at William Blair upped their Q1 2018 EPS estimates for shares of Express Scripts in a report issued on Tuesday. William Blair analyst J. Kreger now forecasts that the company will post earnings of $1.93 per share for the quarter, up from their previous estimate of $1.61. William Blair also issued estimates for Express Scripts’ Q2 2018 earnings at $2.37 EPS, Q3 2018 earnings at $2.44 EPS, Q4 2018 earnings at $2.63 EPS, FY2018 earnings at $9.37 EPS, Q1 2019 earnings at $2.17 EPS, Q2 2019 earnings at $2.49 EPS, Q3 2019 earnings at $2.68 EPS, Q4 2019 earnings at $2.95 EPS, FY2019 earnings at $10.28 EPS, FY2020 earnings at $9.10 EPS and FY2021 earnings at $8.10 EPS.

A number of other research firms have also recently commented on ESRX. Robert W. Baird reaffirmed a “buy” rating and issued a $92.00 target price (up previously from $81.00) on shares of Express Scripts in a research report on Tuesday. Evercore ISI assumed coverage on shares of Express Scripts in a research report on Thursday, January 4th. They issued an “in-line” rating and a $78.00 target price on the stock. BidaskClub raised shares of Express Scripts from a “buy” rating to a “strong-buy” rating in a research report on Friday, December 22nd. SunTrust Banks set a $86.00 target price on shares of Express Scripts and gave the company a “buy” rating in a research report on Thursday, December 21st. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Express Scripts in a research report on Thursday, December 21st. Five equities research analysts have rated the stock with a sell rating, ten have given a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company’s stock. Express Scripts currently has an average rating of “Hold” and an average target price of $76.52.

Express Scripts (NASDAQ ESRX) opened at $80.68 on Thursday. Express Scripts has a 1 year low of $55.80 and a 1 year high of $80.76. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61. The company has a market cap of $45,510.00, a PE ratio of 13.40, a price-to-earnings-growth ratio of 1.01 and a beta of 0.87.

Express Scripts (NASDAQ:ESRX) last posted its earnings results on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, meeting the Zacks’ consensus estimate of $1.90. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The company had revenue of $24.68 billion for the quarter, compared to analysts’ expectations of $25.68 billion. During the same quarter in the prior year, the company posted $1.74 earnings per share. Express Scripts’s revenue for the quarter was down 2.9% compared to the same quarter last year.

Express Scripts announced that its board has authorized a share buyback program on Monday, December 18th that permits the company to buyback 45,000,000 outstanding shares. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board believes its shares are undervalued.

In related news, VP Glen D. Stettin sold 3,448 shares of the company’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total transaction of $262,048.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Christine Houston sold 10,104 shares of the company’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $70.08, for a total transaction of $708,088.32. Following the sale, the vice president now owns 87,400 shares in the company, valued at $6,124,992. The disclosure for this sale can be found here. Insiders have sold 14,195 shares of company stock worth $1,010,240 in the last three months. Corporate insiders own 0.68% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the stock. Burt Wealth Advisors increased its stake in shares of Express Scripts by 11.4% during the second quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after buying an additional 174 shares during the period. Bank of Nova Scotia Trust Co. purchased a new stake in shares of Express Scripts during the third quarter worth approximately $120,000. Monroe Bank & Trust MI increased its stake in shares of Express Scripts by 74.8% during the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock worth $156,000 after buying an additional 970 shares during the period. Capstone Investment Advisors Netherlands B.V. increased its stake in shares of Express Scripts by 49.3% during the second quarter. Capstone Investment Advisors Netherlands B.V. now owns 2,797 shares of the company’s stock worth $179,000 after buying an additional 924 shares during the period. Finally, Nelson Roberts Investment Advisors LLC purchased a new stake in shares of Express Scripts during the third quarter worth approximately $193,000. Hedge funds and other institutional investors own 88.28% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Q1 2018 EPS Estimates for Express Scripts Holding Lifted by Analyst (ESRX)” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece of content can be viewed at https://www.watchlistnews.com/q1-2018-eps-estimates-for-express-scripts-holding-lifted-by-analyst-esrx/1802887.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Earnings History and Estimates for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with Analyst Ratings Network's FREE daily email newsletter.